Want to see VIR full AI Analyst Report?
Vir Biotechnology (VIR) Income Statement
Vir Biotechnology Income Statement
Last quarter (Q2 2026), Vir Biotechnology's total revenue was $238.95M, an increase of 19582.54% from the same quarter last year. In Q2, Vir Biotechnology's net income was $80.08M. See Vir Biotechnology’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 68.56M | $ 74.20M | $ 86.18M | $ 1.62B | $ 1.10B | |
| $ 56.85M | $ 58.80M | $ 63.96M | $ 1.45B | $ 1.02B | |
| $ 524.87M | $ 582.22M | $ 724.97M | $ 620.92M | $ 602.99M | |
| Depreciation and Amortization | $ 11.68M | $ 14.56M | $ 19.45M | $ 15.49M | $ 11.98M |
| $ -456.34M | $ -508.86M | $ -641.55M | $ 848.56M | $ 432.73M | |
| $ -468.02M | $ -523.42M | $ -661.00M | $ 833.07M | $ 420.75M | |
| $ 30.25M | $ 316.00K | $ 32.81M | $ -78.79M | $ 129.05M | |
| $ -437.77M | $ -523.11M | $ -628.19M | $ 754.28M | $ 549.80M | |
| $ -437.99M | $ -521.96M | $ -615.06M | $ 515.84M | $ 528.58M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.16 | $ -3.83 | $ -4.59 | $ 3.89 | $ 4.07 |
| Diluted EPS | $ -3.16 | $ -3.83 | $ -4.59 | $ 3.83 | $ 3.96 |
| Weighted Average Shares Outstanding | 138.52M | 136.25M | 134.13M | 132.61M | 129.88M |
| Weighted Average Shares Outstanding (Diluted) | 138.52M | 136.25M | 134.13M | 134.81M | 133.44M |
Currency in USD
